1. Centers for Disease Control
and Prevention. Monitoring Selected
National HIV Prevention and Care Objectives by Using HIV Surveillance
Data: United States and 6 Dependent Areas, 2015; HIV Surveillance
Supplemental Report 2017; July 2017; Vol. 22 (No. 2). https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html (accessed February 17, 2020).
2. National
HIV/AIDS Strategy for The United States (Updated for 2020). https://www.hiv.gov/federal-response/national-hiv-aids-strategy/overview (accessed February 17, 2020).
3. Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor
4. bKohgo, S.; Ohrui, H.; Kodama, E.; Matsuoka, M.; Mitsuya, H. 4′-C-Substituted-2-halo-adenosine derivative. Can. Pat. CA 2502109, March 22, 2005.
5. Design, Efficient Synthesis, and Anti‐HIV Activity of 4′‐C‐Cyano‐ and 4′‐C‐Ethynyl‐2′‐deoxy Purine Nucleosides